Last reviewed · How we verify
NCT04355299
A Short-term Mixed Exercise for Sarcopenic Hospitalized Aged 80+ Years
NA trial testing balance training in Sarcopenia in 121 participants. Completed in 1 January 2020.
30 December 2019
Quick facts
| Lead sponsor | Yuxiang Liang |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 121 |
| Start date | 1 October 2016 |
| Primary completion | 30 December 2019 |
| Estimated completion | 1 January 2020 |
Drugs / interventions tested
- balance training
- resistance training
- aerobic exercise — full drug profile →
- usual care
Conditions studied
- Sarcopenia — all drugs for Sarcopenia →
Sponsor
Yuxiang Liang
Who can join
Adults 80 to 102, any sex, with Sarcopenia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Most previous clinical trials that addressed exercise for sarcopenic elderly subjects focused on community-dwelling older adults who were relatively healthy. There is a notable paucity of high-quality research investigating the effects and feasibility of exercise for hospitalized or institutionalized older people, who are generally frailer and more severe in functional impairment than those living in the community. Moreover, most reported exercise programs were of long-term duration, which typically lasted 3 to 6 months with two sessions per week. It remains unclear whether short-term exercise would be effective for treating sarcopenia. Therefore, the investigators aimed to assess the effectiveness of short-term exercise for treating sarcopenia in hospitalized older patients aged 80 years and over.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04355299
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of balance training
Trials testing the same drug.
- NCT06615089 — Effect Of Balance Training With Foot Orthosis On Falling In Elderly · NA · not yet recruiting
- NCT06768112 — Non-Invasive Vagus Nerve Stimulation Combine Postural Training in the Elderly · NA · active not recruiting
- NCT06502652 — Hippotherapy Versus Balance Therapy on Funvtional Mobility in Down Syndrome · NA · completed
- NCT06509685 — Effects of Ladder Versus Balance Training on Dynamic Balance and Performance Among Football Players · NA · completed
- NCT05341804 — Cognitive and Balance Dual Task Training for People With Schizophrenia · NA · completed
Other recruiting trials for Sarcopenia
Currently open trials in the same condition.
- NCT07500376 — Multimodal Nutritional and Sarcopenia Assessment for Risk Stratification in Lung Cancer Surgery · recruiting
- NCT07456956 — HIIT vs MCIT for Stroke-Related Sarcopenia in Ischemic Stroke · NA · recruiting
- NCT07398495 — Multimodal Training Effects in Middle-Aged and Older Adults With Diabetic Sarcopenia · NA · recruiting
- NCT07494916 — Effects of Functional Task Training on Muscle Health and Function in Older Adults With Sarcopenia · NA · active not recruiting
- NCT07426159 — AI-Guided Sarcopenia Risk Assessment and Detection · NA · active not recruiting
Other Yuxiang Liang trials
Trials by the same sponsor.
- NCT04637789 — The Whole Body Vibration for Sarcopenic Hospitalized Patients Aged 80+ Years · NA · completed
- NCT04497480 — The Extremities Rehabilitation Training System for Sarcopenic Hospitalized Aged 80+ Years · NA · unknown
- NCT04216368 — Balance Trainning for Sarcopenic Inpatients Aged 80+ Years · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04355299 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Yuxiang Liang
- Last refreshed: 22 April 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04355299.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing